Conv. Plasma
Nigella Sativa
Nitric Oxide
Peg.. Lambda

Home   COVID-19 treatment studies for Vitamin D  COVID-19 treatment studies for Vitamin D  C19 studies: Vitamin D  Vitamin D   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ ICU admission 52% Improvement Relative Risk Panagiotou et al. Vitamin D for COVID-19 Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Retrospective 134 patients in the United Kingdom Lower ICU admission with higher vitamin D levels (p=0.02) Panagiotou et al., medRxiv, doi:10.1101/2020.06.21.20136903 Favors vitamin D Favors control
Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalised with COVID-19 are associated with greater disease severity: results of a local audit of practice
Panagiotou et al., medRxiv, doi:10.1101/2020.06.21.20136903 (Preprint)
Panagiotou et al., Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalised with COVID-19 are associated with.., medRxiv, doi:10.1101/2020.06.21.20136903 (Preprint)
Jun 2020   Source   PDF  
  All Studies   Meta
Retrospective analysis 134 hospitalized patients. 19% of ICU patients had 25(OH)D levels > 50 nmol/L vs. 39.1% of non-ICU patients, p=0.02
This is the 4th of 175 COVID-19 sufficiency studies for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 18 vigintillion).
risk of ICU admission, 52.0% lower, RR 0.48, p = 0.02, high D levels 8 of 44 (18.2%), low D levels 34 of 90 (37.8%), NNT 5.1, >50nmol/L.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Panagiotou et al., 30 Jun 2020, retrospective, United Kingdom, preprint, 12 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin DAll
Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalised with COVID-19 are associated with greater disease severity: results of a local audit of practice
Grigorios Panagiotou, Su Ann Tee, Yasir Ihsan, Waseem Athar, Gabriella Marchitelli, Donna Kelly, Christopher S Boot, Nadia Stock, James Macfarlane, Adrian R Martineau, Graham Burns, Dr Richard Quinton
Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalised with COVID-19 are associated with greater disease severity: results of a local audit of practice.
manuscript. RQ is the guarantor of this work and attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted.
Alipio, Vitamin D Supplementation Could Possibly Improve Clinical Outcomes of Patients Infected with Coronavirus, COVID
Aranow, Vitamin D and the immune system, Journal of investigative medicine : the official publication of the American Federation for Clinical Research, doi:10.2310/JIM.0b013e31821b8755
Aspell, Laird, Healy, The Prevalence and Determinants of Vitamin D Status in Community-Dwelling Older Adults: Results from the English Longitudinal Study of Ageing (ELSA), Nutrients, doi:10.3390/nu11061253
Berry, Hesketh, Power, Vitamin D status has a linear association with seasonal infections and lung function in British adults, The British journal of nutrition, doi:10.1017/S0007114511001991
Covid, 19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients
Daneshkhah, Agrawal, Eshein, The Possible Role of Vitamin D in Suppressing Cytokine Storm and Associated Mortality in COVID-19 Patients, medRxiv, doi:10.1101/2020.04.08.20058578
Glicio, Vitamin D Level of Mild and Severe Elderly Cases of COVID-19: A Preliminary Report
Goldacre, Hall, Yeates, Hospitalisation for children with rickets in England: a historical perspective, Lancet, doi:10.1016/S0140-6736(14)60211-7
Grant, Lahore, Mcdonnell, Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths, Nutrients, doi:10.3390/nu12040988
Gruber-Bzura, Vitamin D and Influenza-Prevention or Therapy?, International journal of molecular sciences, doi:10.3390/ijms19082419
Hastie, Mackay, Ho, Vitamin D concentrations and COVID-19 infection in UK Biobank, Diabetes & metabolic syndrome, doi:10.1016/j.dsx.2020.04.050
Hill, Granic, Davies, Serum 25-hydroxyvitamin D concentration and its determinants in the very old: the Newcastle 85+ Study. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis, Foundation, doi:10.1007/s00198-015-3366-9
Hypponen, Power, Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors, The American journal of clinical nutrition, doi:10.1093/ajcn/85.3.860
Ilie, Stefanescu, Smith, The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality, Aging clinical and experimental research, doi:10.1007/s40520-020-01570-8
Jin, Bai, He, Gender Differences in Patients With COVID-19: Focus on Severity and Mortality, Frontiers in public health, doi:10.3389/fpubh.2020.00152
Jolliffe, Stefanidis, Wang, Vitamin D Metabolism is Dysregulated in Asthma and Chronic Obstructive Pulmonary Disease, American journal of respiratory and critical care medicine, doi:10.1164/rccm.201909-1867OC
Khare, Godbole, Pawar, None, Calcitriol
Khunti, De Bono, Browne, Risk Reduction Framework for NHS staff at risk of COVID-19 infection, Faculty of Occupational Medicine
Khunti, Singh, Pareek, Is ethnicity linked to incidence or outcomes of covid-19?, Bmj, doi:10.1136/bmj.m1548
Lau, Majumder, Torabi, Vitamin D Insufficiency is Prevalent in Severe COVID-19, medRxiv, doi:10.1101/2020.04.24.20075838
Martineau, Jolliffe, Hooper, Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data, Bmj, doi:10.1136/bmj.i6583
Nonnecke, Mcgill, Ridpath, Acute phase response elicited by experimental bovine diarrhea virus (BVDV) infection is associated with decreased vitamin D and E status of vitamin-replete preruminant calves, Journal of dairy science, doi:10.3168/jds.2014-8293
Pap, Sadiah, Budiarti, Agung, Budi, Patterns of COVID-19 Mortality and Vitamin D: An Indonesian Study
Pearce, Cheetham, Diagnosis and management of vitamin D deficiency, Bmj, doi:10.1136/bmj.b5664
Pereira-Santos, Costa, Assis, Obesity and vitamin D deficiency: a systematic review and meta-analysis, International Association for the Study of Obesity, doi:10.1111/obr.12239
Rhodes, Subramanian, Laird, Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity, Alimentary pharmacology & therapeutics, doi:10.1111/apt.15777
Romagnoli, Mascia, Cipriani, Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly, The Journal of clinical endocrinology and metabolism, doi:10.1210/jc.2008-0350
Ruiz-Irastorza, Egurbide, Olivares, Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences, Rheumatology, doi:10.1093/rheumatology/ken121
Silberstein, Vitamin, A simpler alternative to tocilizumab for trial in COVID-19?, Medical hypotheses, doi:10.1016/j.mehy.2020.109767
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop